Fabry Disease: Thirty-five Mutations in the Alpha-galactosidase A Gene in Patients with Classic and Variant Phenotypes

Overview

Journal Mol Med

Publisher Biomed Central

Specialties General Medicine
Molecular Biology

Date 1997 Mar 1

PMID 9100224

Citations 46

Authors

C M Eng

G A Ashley

T S Burgert

A L Enriquez

M DSouza

R J Desnick

Affiliations

Soon will be listed here.

Abstract

Background: Fabry disease, an X-linked inborn error of glycosphingolipid catabolism, results from mutations in the alpha-galactosidase A (alpha-Gal A) gene located at Xq22.1. To determine the nature and frequency of the molecular lesions causing the classical and milder variant Fabry phenotypes and for precise carrier detection, the alpha-Gal A lesions in 42 unrelated Fabry hemizygotes were determined.

Materials And Methods: Genomic DNA was isolated from affected probands and their family members. The seven alpha-galactosidase A exons and flanking intronic sequences were PCR amplified and the nucleotide sequence was determined by solid-phase direct sequencing.

Results: Two patients with the mild cardiac phenotype had missense mutations, I9IT and F113L, respectively. In 38 classically affected patients, 33 new mutations were identified including 20 missense (MIT, A31V, H46R, Y86C, L89P, D92Y, C94Y, A97V, R100T, Y134S, G138R, A143T, S148R, G163V, D170V, C202Y, Y216D, N263S, W287C, and N298S), two nonsense (Q386X, W399X), one splice site mutation (IVS4 + 2T-->C), and eight small exonic insertions or deletions (304del1, 613del9, 777del1, 1057del2, 1074del2, 1077del1, 1212del3, and 1094ins1), which identified exon 7 as a region prone to gene rearrangements. In addition, two unique complex rearrangements consisting of contiguous small insertions and deletions were found in exons 1 and 2 causing L45R/H46S and L120X, respectively.

Conclusions: These studies further define the heterogeneity of mutations causing Fabry disease, permit precise carrier identification and prenatal diagnosis in these families, and facilitate the identification of candidates for enzyme replacement therapy.

Citing Articles

Long-read sequencing enables comprehensive molecular genetic diagnosis of Fabry disease.

Yao F, Hao N, Li D, Zhang W, Zhou J, Qiu Z Hum Genomics. 2024; 18(1):133.

PMID: 39609713 PMC: 11603755. DOI: 10.1186/s40246-024-00697-3.

Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women.

Faro D, Losi V, Rodolico M, Torrisi E, Colomba P, Duro G Genes (Basel). 2023; 14(9).

PMID: 37761944 PMC: 10531426. DOI: 10.3390/genes14091804.

Difficulties in Diagnosing Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy (LVH): Is the Novel GLA Gene Mutation a Pathogenic Mutation or Polymorphism?.

Aladag N, Ali Barman H, Sipal A, Akbulut T, Ozdemir M, Ceylaner S Balkan J Med Genet. 2023; 26(1):43-50.

PMID: 37576794 PMC: 10413883. DOI: 10.2478/bjmg-2023-0010.

Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families.

Cianci V, Pascarella A, Manzo L, Gasparini S, Marsico O, Mammi A Metab Brain Dis. 2023; 38(6):1905-1912.

PMID: 37097439 PMC: 10348951. DOI: 10.1007/s11011-023-01216-4.

Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease.

Cybulla M, Nicholls K, Feriozzi S, Linhart A, Torras J, Vujkovac B J Clin Med. 2022; 11(16).

PMID: 36013057 PMC: 9410255. DOI: 10.3390/jcm11164810.

References

Desnick R, Allen K, Desnick S, Raman M, BERNLOHR R, Krivit W . Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med. 1973; 81(2):157-71. View

Davies J, Eng C, Hill J, Malcolm S, Macdermot K, Winchester B . Fabry disease: fourteen alpha-galactosidase A mutations in unrelated families from the United Kingdom and other European countries. Eur J Hum Genet. 1996; 4(4):219-24. DOI: 10.1159/000472202. View

Cooper D, Youssoufian H . The CpG dinucleotide and human genetic disease. Hum Genet. 1988; 78(2):151-5. DOI: 10.1007/BF00278187. View

Bishop D, Kornreich R, Desnick R . Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region. Proc Natl Acad Sci U S A. 1988; 85(11):3903-7. PMC: 280328. DOI: 10.1073/pnas.85.11.3903. View

Gibbs R, Nguyen P, McBride L, Koepf S, Caskey C . Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA. Proc Natl Acad Sci U S A. 1989; 86(6):1919-23. PMC: 286816. DOI: 10.1073/pnas.86.6.1919. View

Bernstein H, Bishop D, Astrin K, Kornreich R, Eng C, Sakuraba H . Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene. J Clin Invest. 1989; 83(4):1390-9. PMC: 303833. DOI: 10.1172/JCI114027. View

Kornreich R, Desnick R, Bishop D . Nucleotide sequence of the human alpha-galactosidase A gene. Nucleic Acids Res. 1989; 17(8):3301-2. PMC: 317741. DOI: 10.1093/nar/17.8.3301. View

Hostikka S, Eddy R, Byers M, Hoyhtya M, Shows T, Tryggvason K . Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci U S A. 1990; 87(4):1606-10. PMC: 53524. DOI: 10.1073/pnas.87.4.1606. View

Nogueira C, Mcguire M, Graeser C, Bartels C, Arpagaus M, van der Spek A . Identification of a frameshift mutation responsible for the silent phenotype of human serum cholinesterase, Gly 117 (GGT----GGAG). Am J Hum Genet. 1990; 46(5):934-42. PMC: 1683584. View

10.

Barker D, Hostikka S, Zhou J, Chow L, Oliphant A, Gerken S . Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990; 248(4960):1224-7. DOI: 10.1126/science.2349482. View

11.

Sakuraba H, Oshima A, Fukuhara Y, Shimmoto M, Nagao Y, Bishop D . Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease. Am J Hum Genet. 1990; 47(5):784-9. PMC: 1683686. View

12.

von Scheidt W, Eng C, Fitzmaurice T, Erdmann E, Hubner G, Olsen E . An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med. 1991; 324(6):395-9. DOI: 10.1056/NEJM199102073240607. View

13.

Cooper D, Krawczak M . Mechanisms of insertional mutagenesis in human genes causing genetic disease. Hum Genet. 1991; 87(4):409-15. DOI: 10.1007/BF00197158. View

14.

Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F . The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993; 361(6409):226-33. DOI: 10.1038/361226a0. View

15.

Kornreich R, Desnick R . Fabry disease: detection of gene rearrangements in the human alpha-galactosidase A gene by multiplex PCR amplification. Hum Mutat. 1993; 2(2):108-11. DOI: 10.1002/humu.1380020208. View

16.

Pease L, Horton R, Pullen J, Yun T . Unusual mutation clusters provide insight into class I gene conversion mechanisms. Mol Cell Biol. 1993; 13(7):4374-81. PMC: 360000. DOI: 10.1128/mcb.13.7.4374-4381.1993. View

17.

Eng C, Niehaus D, Astrin K, Desnick R . Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease. Am J Hum Genet. 1993; 53(6):1186-97. PMC: 1682507. View

18.

Eng C, Desnick R . Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene. Hum Mutat. 1994; 3(2):103-11. DOI: 10.1002/humu.1380030204. View

19.

Kobayashi T, Yanagi H, Shimakura Y, Satoh J, Hamaguchi H . A novel complex mutation in the LDL receptor gene probably caused by the simultaneous occurrence of deletion and insertion in the same region. Hum Genet. 1994; 93(6):625-8. DOI: 10.1007/BF00201560. View

20.

Eng C, Niehaus D, Enriquez A, Burgert T, Ludman M, Desnick R . Fabry disease: twenty-three mutations including sense and antisense CpG alterations and identification of a deletional hot-spot in the alpha-galactosidase A gene. Hum Mol Genet. 1994; 3(10):1795-9. DOI: 10.1093/hmg/3.10.1795. View